Tag:
Patheon
Latest Headlines
Latest Headlines
Patheon exiting most manufacturing at U.K. plant
The company also plans to move to other facilities most of its product development work at Swindon that requires commercialization.
Big quarterly loss whacks ex-Biogen chief's CMO amid transition
Wait until the second half of the fiscal year was Patheon ($PTI) CEO Jim Mullen's message after the contract drugmaker reported a $20.9 million loss.
Patheon ops 'transformation' aligns with Q4 losses
Contract manufacturer Patheon is "successfully executing on [its] transformation," says CEO Jim Mullen. "In the locations where we have rolled out our operational excellence programs, we have already
Patheon reveals strategy amid poor financials
James Mullen, the former CEO of Biogen Idec ( $BIIB ), is facing some new challenges at the helm of contract manufacturing outfit Patheon ($TSX:PTI). Mullen, who stepped up as CEO and president in
Ex-Biogen CEO Mullen takes helm at Patheon
After riding a career arc that took him to the top of Biogen Idec over a 21-year stint--ending in a battle royale with Carl Icahn that opened the door to his departure--James Mullen is moving on to
CMO gets opioid deal
Australian drug maker QRxPharma (ASX: QRX and OTCQX: QRXPY) has enlisted New Jersey-based contract manufacturer Patheon to manufacture clinical supplies of a controlled-release pain relief
Lonza offers $460M for Patheon
Lonza Group has swooped in to rescue pharmaceutical industry supplier Patheon from a hostile takeover by private equity firm JLL Partners. In March, JLL made a $259 million bid for Patheon. The
